BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on our proprietary basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
Location: Israel, Jerusalem District, Jerusalem
Employees: 1-10
Founded date: 2017